SODIUM 9-((E)-4-((2R,3S,4AS,7S,8S,8AR)-3,8-DIHYDROXY-2-((2S,3S)-3-HYDROXYBUTAN-2-YL)-2,3,4,4A,5,7,8,8A-OCTAHYDROPYRANO(3,2-C)PYRAN-7-YL)-3-METHYLBUT-2-ENOYL)OXYNONANOATE
UNII DHD6GS3G48
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 9-((e)-4-((2r,3s,4as,7s,8s,8ar)-3,8-dihydroxy-2-((2s,3s)-3-hydroxybutan-2-yl)-2,3,4,4a,5,7,8,8a-octahydropyrano(3,2-c)pyran-7-yl)-3-methylbut-2-enoyl)oxynonanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DHD6GS3G48.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 116182-44-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H43O9.Na XZMQVUOWANJXDT-WENNQWSDSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 9-((e)-4-((2r,3s,4as,7s,8s,8ar)-3,8-dihydroxy-2-((2s,3s)-3-hydroxybutan-2-yl)-2,3,4,4a,5,7,8,8a-octahydropyrano(3,2-c)pyran-7-yl)-3-methylbut-2-enoyl)oxynonanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.